These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24402990)

  • 1. Vitamin D and prostate cancer survival in veterans.
    Der T; Bailey BA; Youssef D; Manning T; Grant WB; Peiris AN
    Mil Med; 2014 Jan; 179(1):81-4. PubMed ID: 24402990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D status and monitoring in female veterans.
    Alazzeh A; Cooper MM; Bailey B; Youssef DA; Manning T; Peiris AN
    Women Health; 2015; 55(4):367-77. PubMed ID: 25866148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D status: ready for guiding prostate cancer diagnosis and treatment?
    Grant WB
    Clin Cancer Res; 2014 May; 20(9):2241-3. PubMed ID: 24789031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are 25-hydroxyvitamin D levels adequately monitored following evidence of vitamin D insufficiency in veterans?
    Peiris AN; Bailey BA; Manning T; Adebonojo L
    Mil Med; 2010 Jun; 175(6):453-6. PubMed ID: 20572480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison between vitamin d concentration in upper silesia patients with prostate cancer and with benign prostatic hyperplasia.
    Wieczorek K; Braczkowski RS; Skrzypek M; Stryjewski PJ; Kuczaj A; Al-Srory G
    J Biol Regul Homeost Agents; 2015; 29(1):207-11. PubMed ID: 25864760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of vitamin D monitoring and status to bladder cancer survival in veterans.
    Peiris AN; Bailey BA; Manning T
    South Med J; 2013 Feb; 106(2):126-30. PubMed ID: 23380747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and intervention trials in prostate cancer: from theory to therapy.
    Schwartz GG
    Ann Epidemiol; 2009 Feb; 19(2):96-102. PubMed ID: 18619854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between pre-treatment serum 25-hydroxyvitamin D and survival in newly diagnosed stage IV prostate cancer.
    Gupta D; Trukova K; Popiel B; Lammersfeld C; Vashi PG
    PLoS One; 2015; 10(3):e0119690. PubMed ID: 25774530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy.
    Nyame YA; Murphy AB; Bowen DK; Jordan G; Batai K; Dixon M; Hollowell CM; Kielb S; Meeks JJ; Gann PH; Macias V; Kajdacsy-Balla A; Catalona WJ; Kittles R
    J Clin Oncol; 2016 Apr; 34(12):1345-9. PubMed ID: 26903577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D insufficiency is common in patients with nonmetastatic prostate cancer.
    Choo CS; Mamedov A; Chung M; Choo R; Kiss A; Danjoux C
    Nutr Res; 2011 Jan; 31(1):21-6. PubMed ID: 21310302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D and prostate cancer risk: a review of the epidemiological literature.
    Gupta D; Lammersfeld CA; Trukova K; Lis CG
    Prostate Cancer Prostatic Dis; 2009; 12(3):215-26. PubMed ID: 19350051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of vitamin D in cancer prevention.
    Garland CF; Garland FC; Gorham ED; Lipkin M; Newmark H; Mohr SB; Holick MF
    Am J Public Health; 2006 Feb; 96(2):252-61. PubMed ID: 16380576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of living in rural and urban areas: vitamin D and medical costs in veterans.
    Bailey BA; Manning T; Peiris AN
    J Rural Health; 2012; 28(4):356-63. PubMed ID: 23017006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a model predictive of vitamin D status be developed from common laboratory tests and demographic parameters?
    Peiris AN; Bailey BA; Guha BN; Copeland R; Manning T
    South Med J; 2011 Sep; 104(9):636-9. PubMed ID: 21886082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline serum 25-hydroxyvitamin d levels in men undergoing radical prostatectomy: is there an association with adverse pathologic features?
    Berg WT; Shapiro EY; Rothberg MB; Bergman A; Scarberry K; Wambi C; Patel T; Badani KK
    Clin Genitourin Cancer; 2014 Oct; 12(5):330-4. PubMed ID: 24680790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D deficiency and insufficiency among patients with prostate cancer.
    Trump DL; Chadha MK; Sunga AY; Fakih MG; Ashraf U; Silliman CG; Hollis BW; Nesline MK; Tian L; Tan W; Johnson CS
    BJU Int; 2009 Oct; 104(7):909-14. PubMed ID: 19426195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low vitamin D status is associated with inflammation in patients with prostate cancer.
    Xie DD; Chen YH; Xu S; Zhang C; Wang DM; Wang H; Chen L; Zhang ZH; Xia MZ; Xu DX; Yu DX
    Oncotarget; 2017 Mar; 8(13):22076-22085. PubMed ID: 28423553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and cancer incidence in the Harvard cohorts.
    Giovannucci E
    Ann Epidemiol; 2009 Feb; 19(2):84-8. PubMed ID: 18291673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can vitamin D supplementation reduce prostate cancer disparities?
    Batai K; Kittles RA
    Pharmacogenomics; 2016 Jul; 17(10):1117-1120. PubMed ID: 27380910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.